BUSATO, DAVIDE
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.014 secondi).
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
2023-01-01 Busato, Davide; Capolla, Sara; Durigutto, Paolo; Mossenta, Monica; Bozzer, Sara; Sblattero, Daniele; Macor, Paolo; Dal Bo, Michele; Toffoli, Giuseppe
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients
2021-01-01 Bedon, L.; Dal Bo, M.; Mossenta, M.; Busato, D.; Toffoli, G.; Polano, M.
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
2020-01-01 Mossenta, Monica; Busato, Davide; Dal Bo, Michele; Toffoli, Giuseppe
Glypican 1-targeted therapeutic approaches adopting doxorubicin-loaded chitosan nanobubbles and antibody-based strategy in the context of Pancreatic Ductal Adenocarcinoma
2022-09-19 Busato, Davide
New insight into therapies targeting angiogenesis in hepatocellular carcinoma
2019-01-01 Mossenta, Monica; Busato, Davide; Baboci, Lorena; DI CINTIO, Federica; Toffoli, Giuseppe; Dal Bo, Michele